Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Botai Branch	1.93B	-	-	-	-
Twinings Branch	5.76B	-	-	3.23B	-
Other Business Segments	14.41B	-	-	14.20B	-
Intersegment Offset	-287.94M	-	-	-150.51M	-
Pharmaceutical Manufacturing	-	-	-	-	16.13B
Pharmaceutical Manufacturing Growth	-	-	-	-	-8.55%
Unallocated Other	-	-	-	-	336.60M
Total	21.81B	-	-	17.28B	16.46B
Total Growth	-	-	-	4.94%	-6.65%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
International Business	2.89B	2.59B	1.40B	903.85M	870.41M
International Business Growth	11.49%	84.80%	54.95%	3.84%	-
South China	1.39B	1.17B	1.31B	1.42B	1.32B
South China Growth	19.53%	-10.78%	-7.93%	7.37%	-
North-East Region	751.91M	832.96M	800.21M	885.51M	933.83M
North-East Region Growth	-9.73%	4.09%	-9.63%	-5.17%	-
Northern China	2.31B	2.24B	2.23B	2.16B	1.90B
Northern China Growth	3.27%	0.63%	2.88%	13.94%	-
Eastern China	5.71B	5.44B	4.34B	3.64B	3.48B
Eastern China Growth	4.94%	25.22%	19.25%	4.80%	-
Central China	2.82B	3.09B	3.44B	3.31B	3.01B
Central China Growth	-8.80%	-10.01%	3.75%	9.86%	-
North-West China	1.31B	1.25B	1.03B	972.32M	1.13B
North-West China Growth	4.56%	21.82%	5.84%	-13.83%	-
Southwest China	4.63B	4.84B	4.50B	3.98B	3.82B
Southwest China Growth	-4.40%	7.70%	13.01%	4.13%	-
Total	21.81B	21.45B	19.04B	17.28B	16.46B
Total Growth	1.67%	12.69%	10.19%	4.94%	-

Source: S&P Global Market Intelligence.